Pyxis Oncology
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $2,820 | $0 | $3,402 | $0 |
Gross Profit | 2,820 | -552 | 1,701 | -731 |
EBITDA | -19,215 | -22,914 | -18,555 | -23,023 |
EBIT | -19,750 | -23,466 | -19,105 | -23,754 |
Net Income | -18,354 | -21,158 | -35,571 | -21,203 |
Net Change In Cash | 2,820 | 0 | 3,402 | 0 |
Free Cash Flow | -17,263 | -22,535 | -19,290 | -14,665 |
Cash | 10,733 | 12,759 | 19,473 | 12,056 |
Basic Shares | 61,918 | 61,048 | 60,715 | 60,715 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $16,146 | $0 | $0 | $0 |
Gross Profit | 15,671 | -2,000 | -1,836 | -1,251 |
EBITDA | -65,514 | -78,493 | -122,772 | -69,070 |
EBIT | -68,496 | -80,493 | -123,481 | -70,321 |
Net Income | -77,331 | -73,790 | -117,953 | -81,536 |
Net Change In Cash | 16,146 | 0 | 0 | 0 |
Cost of Revenue | -95,551 | 268,128 | ||
Free Cash Flow | -57,909 | -77,435 | -95,734 | -35,866 |
Cash | 19,473 | 9,664 | 179,293 | 274,735 |
Basic Shares | 58,445 | 39,904 | 33,033 | 32,222 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.30 |
2025-03-31 | -$0.35 |
2024-12-31 | -$1.32 |
